Biocon all clear, Dr Reddy's stays under scrutiny: US FDA Indian audit round-up
The US FDA has issued Establishment Inspection Reports (EIRs) closing out inspections at Biocon’s biomanufacturing plant in Bangalore and a Divi’s Lab facility in Visakhapatnam.